openPR Logo
Press release

China Potential Non–Invasive Prenatal Testing (NIPT) Market Surpass US$ 1.7 Billion by 2024

09-12-2017 10:58 AM CET | Health & Medicine

Press release from: Market Research Sphere

China Potential Non–Invasive Prenatal Testing (NIPT) Market

China Potential Non–Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024.

Long–term Growth Projection and Development:

• It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024
• More than 3,00,000 NIFTY tests done in 2016
• Berry Genomics completes US$ 648 Million reverse merger in Shenzhen
• Two–Child policy is likely to boost China NIPT market

Growth in China NIPT market can be attributed to factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT and shifting trend towards child bearing at advanced maternal age (35 years or older). High test cost, strict regulatory requirements and ethical hurdles is restraining the growth of China NIPT market. Due to expanding patient access to NIPT test, the China NIPT test market is poised to have a positive outlook in the year ahead.

The research report titled “Non–Invasive Prenatal Testing(NIPT) Market Outlook 2024: China Opportunity and Demand Analysis, Market Forecast 2017–2024” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the China actual and potential NIPT market.

The report contains a granular analysis of the market segmentation, reveal facts on the market size, volume and revenues; and provides forecasts through 2024. It also includes a snapshot of the NIPT implementation in the low and middle-income countries. The report also explores detailed description of growth drivers and inhibitors of the China NIPT Market.

The report concludes with the profiles of major players in the China NIPT Market. The key market players are evaluated on various parameters such as company introduction, NIPT test portfolio, NIPT test analysis with volume and market revenue and latest development/updates of the NIPT Market in China.

Complete Report @ http://www.dpiresearch.com/report-details.php?P_ID=113

Key Topics Covered in the Report

• 2013 - 2024: China Potential NIPT Test Market Size & Analysis (Volume and Value)
• 2013 - 2024: China Actual NIPT Test Market Size & Analysis (Volume and Value)
• NIPT Test Implementation in Low & Middle–Income Countries
• Key Companies Analysis
• Key Drivers and Inhibitors of the China NIPT Test Market

Key Companies Covered in the Report are as follows:

• Berry Genomics
• BGI Diagnosis Co., Ltd
• Basetra

DPI Research is a business solutions firm which offer bespoke market research reports, custom research solutions and consulting across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.

DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Maria Rai
Tel :+91 -7289949987
Email: sales@dpiresearch.com
Website: www.dpiresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release China Potential Non–Invasive Prenatal Testing (NIPT) Market Surpass US$ 1.7 Billion by 2024 here

News-ID: 710112 • Views: 228

More Releases from Market Research Sphere

Non Invasive Prenatal Testing Market Report 2017
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, country wise actual and potential market, NIPT test analysis with volume and market revenue and competitive landscape. The report also
US Insulin Delivery Devices Market to Be Worth US$ 6 Bn by 2022
DPI Research adds"United States Insulin Delivery Devices Market Outlook 2017: Key Product Categories (Insulin Pumps, Insulin Pens (Reusable, Disposable) Demand, Insights, Analysis, Opportunities, Segmentation and Forecast to 2022" to its databases The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through 2022. A comprehensive analysis has been done on market share of insulin delivery devices segment. Key
At 20% CAGR, Proton Therapy Market US Reach $1 Bn by 2025
The research report titled “United States Proton Therapy Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 - 2025” examines the market dynamics, competitive landscape and discusses major trends. The study describes an in–depth analysis of the United States actual and potential proton therapy market. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, volume, revenues and provides forecasts through
US Proton Therapy Market - IBA Dominates the Market
United States Proton Therapy market is expected to reach nearly US$ 1 Billion, potentially US$ 7 Billion by 2025. Market growth can be attributed to factors such as rising cancer incidence, increasing number of proton therapy centers, decreasing cost of proton therapy treatment, technological advances and market adoption. However, high costs involved in the establishment of the center is likely to restrain growth in the forecast period. The research report titled “United

All 5 Releases


More Releases for NIPT

Non-invasive Prenatal Testing (NIPT) Market - Screening Opportunities 2025
Global Non-invasive Prenatal Testing (NIPT) Market: Overview The growing preference for non-invasive techniques over invasive surgeries is one of the key growth drivers for the global non-invasive prenatal testing (NIPT) market. In addition to this number of babies born with Down syndrome, XYY syndrome, Turner, and Klinefelter is increasing, boosting the growth of the market. These chromosomal aneuploidies occur as a result of infertility, reproductive loss, and language development delays
United States Non-Invasive Prenatal Testing (NIPT) Market 2023
United States Non-Invasive Prenatal Testing (NIPT) Industry United States Non-Invasive Prenatal Testing (NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Latest Report on Non-Invasive Prenatal Testing (NIPT) Market United States Analysis & 2023 Forecast Research Study Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk
China $1.7 NIPT Test Market Outlook 2017-2024
China Potential Non–Invasive Prenatal Testing (NIPT) market is likely to reach more than US$ 1.7 Billion by 2024. Long–term Growth Projection and Development: • It is predicted that China Actual NIPT test volume will increase to 1.6 Million by 2024 • More than 3,00,000 NIFTY tests done in 2016 • Berry Genomics completes US$ 648 Million reverse merger in Shenzhen • Two–Child policy is likely to boost China NIPT market Growth in China NIPT market can
Non-invasive Prenatal Testing (NIPT) Market | Forecast up to 2022
Global Non-invasive Prenatal Testing Market: Snapshot Non-invasive prenatal testing (NIPT) has been garnering higher adoption especially in the cases of high risk pregnant women. Chromosomal disorders such as Edwards syndrome, down syndrome, Turner syndrome, and Patau syndrome are some of the diseases that can be screened using non-invasive prenatal testing. Gynecologists and pregnant women prefer the safety, non-invasiveness, and accuracy of non-invasive prenatal testing technology, although there are other testing techniques
2017 - 2021 : NIPT Test Market & Forecast
The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021. Buy Now @: www.dpiresearch.com/report-details.php?P_ID=93 Long–term Growth Projection: More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021. Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow
2017-2023 : US NIPT Test Market
United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Buy Now @ http://www.dpiresearch.com/report-details.php?P_ID=100 Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of